10.46
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VIR Giù?
Forum
Previsione
Vir Biotechnology Inc Borsa (VIR) Ultime notizie
Vir Biotechnology Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Vir Biotechnology Rings the Closing Bell - Nasdaq
A Look At Vir Biotechnology (VIR) Valuation After New VIR-5500 Prostate Cancer Trial Milestone - Yahoo Finance
VIR SEC FilingsVir Biotechnology, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-targeted, PRO-XTEN® Dual-masked T-cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer - BioSpace
Vir Biotechnology Q1 2025 Earnings Preview - MSN
Vir Biotechnology doses first patient in VIR-5500 expansion trial By Investing.com - Investing.com Australia
Vir Biotechnology (VIR) Advances Phase 1 Trial with First Patien - GuruFocus
Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-ta - PharmiWeb.com
Vir Biotechnology doses first patient in VIR-5500 expansion trial - Investing.com
Vir Biotech CEO Stock Sale: $664K Transaction in April 2026News and Statistics - IndexBox
Vir Biotechnology (VIR) CEO Sells 73,000 Shares for $664,000 - The Motley Fool
Vir Biotechnology (VIR) CEO Sells 73,000 Shares for $664,000 - The Motley Fool
VIR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Vir Biotechnology Announces Upcoming Chief Medical Officer Transition - TipRanks
Vir Biotechnology (NASDAQ: VIR) Chief Medical Officer to step down April 24 - Stock Titan
Quarterly Risk: Can Vir Biotechnology Inc be recession proof2026 Outlook & Weekly High Return Opportunities - baoquankhu1.vn
Vir Biotechnology (VIR) Leading with Its BiTEs Therapy - Insider Monkey
Vir Biotechnology’s CMO Change Already Reflected in Valuation—Attention Shifts to Execution Risks for VIR-5500 - Bitget
Aberdeen Group plc Sells 135,688 Shares of Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Vir Biotechnology CEO de Backer sells $664k in stock By Investing.com - Investing.com Canada
Vir Biotechnology (NASDAQ:VIR) CEO Backer Marianne De Sells 72,559 Shares - MarketBeat
Vir Biotechnology CEO de Backer sells $664k in stock - Investing.com
Vir Biotechnology (VIR) CEO auto-sells 72,559 shares to cover RSU tax - Stock Titan
VIR Biotechnology Inc (NASDAQ:VIR) Emerges as a High-Growth Momentum Pick - ChartMill
Exit Recap: What is the Moat Score of Vir Biotechnology Inc2026 Bull vs Bear & Weekly Momentum Stock Picks - baoquankhu1.vn
VIR (NASDAQ: VIR) Form 144 shows 72,559-share sale after vesting - Stock Titan
Evercore ISI Group Initiates Coverage of Vir Biotechnology (VIR) with Outperform Recommendation - MSN
VIR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Market Catalysts: Is Vir Biotechnology Inc a good stock for dollar cost averaging2026 Key Highlights & AI Powered Market Trend Analysis - baoquankhu1.vn
Insider Sell: Vicki Sato Sells 22,000 Shares of Vir Biotechnology Inc (VIR) - GuruFocus
Vir Biotechnology (NASDAQ:VIR) Director Sells $199,540.00 in Stock - MarketBeat
Vir Biotechnology director Sato sells $199k in shares By Investing.com - za.investing.com
Vir Biotechnology director Sato sells $199k in shares - Investing.com
Vir Biotechnology (VIR) director sells 22,000 shares in open market - Stock Titan
Vir Biotechnology (VIR) price target increased by 26.10% to 20.74 - MSN
Energy Moves: Is Vir Biotechnology Inc stock a smart retirement pickPortfolio Update Report & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Bull Bear: Is Vir Biotechnology Inc stock heavily shortedNew Guidance & Consistent Growth Stock Picks - baoquankhu1.vn
Investor Mood: How volatile is LGLWS stockWeekly Earnings Recap & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Vir Biotechnology, Inc. (VIR) Stock Forecasts - Yahoo Finance
Why did Vir Biotechnology stock surge 60% after-hours today? - MSN
Vanguard affiliates disaggregate holdings; VIR shows 0% ownership (VIR) - Stock Titan
These analysts boost their forecasts on Vir Biotechnology - msn.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):